256 related articles for article (PubMed ID: 34839819)
1. Cenerimod, a selective S1P
Gerossier E; Nayar S; Froidevaux S; Smith CG; Runser C; Iannizzotto V; Vezzali E; Pierlot G; Mentzel U; Murphy MJ; Martinic MM; Barone F
Arthritis Res Ther; 2021 Nov; 23(1):289. PubMed ID: 34839819
[TBL] [Abstract][Full Text] [Related]
2. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
[TBL] [Abstract][Full Text] [Related]
5. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
Hayashi Y; Hamano H; Haneji N; Ishimaru N; Yanagi K
Arthritis Rheum; 1995 Aug; 38(8):1077-84. PubMed ID: 7639803
[TBL] [Abstract][Full Text] [Related]
6. P2Y
Jasmer KJ; Woods LT; Forti KM; Martin AL; Camden JM; Colonna M; Weisman GA
Arch Oral Biol; 2021 Apr; 124():105067. PubMed ID: 33561807
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Saito K; Mori S; Date F; Hong G
Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
[TBL] [Abstract][Full Text] [Related]
8. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
9. Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide.
Li B; Wang F; Schall N; Muller S
J Autoimmun; 2018 Jun; 90():132-145. PubMed ID: 29486915
[TBL] [Abstract][Full Text] [Related]
10. Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren's syndrome.
Wen J; Zhu F; Yu X; Xie H; Li C
BMC Immunol; 2022 Oct; 23(1):49. PubMed ID: 36244973
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Nayar S; Campos J; Smith CG; Iannizzotto V; Gardner DH; Colafrancesco S; Pipi E; Kollert F; Hunter KJ; Brewer C; Buckley CD; Bowman SJ; Priori R; Valesini G; Juarez M; Fahy WA; Fisher BA; Payne A; Allen RA; Barone F
Ann Rheum Dis; 2019 Feb; 78(2):249-260. PubMed ID: 30472652
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
[TBL] [Abstract][Full Text] [Related]
13. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
14. RORγt antagonist improves Sjögren's syndrome-like sialadenitis through downregulation of CD25.
Ono Y; Tsuboi H; Moriyama M; Asashima H; Kudo H; Takahashi H; Honda F; Abe S; Kondo Y; Takahashi S; Matsumoto I; Nakamura S; Sumida T
Oral Dis; 2020 May; 26(4):766-777. PubMed ID: 31837283
[TBL] [Abstract][Full Text] [Related]
15. McH-lpr/lpr-RA1 mice: A novel spontaneous mouse model of autoimmune sialadenitis.
Saito K; Mori S; Kodama T
Immunol Lett; 2021 Sep; 237():3-10. PubMed ID: 34174253
[TBL] [Abstract][Full Text] [Related]
16. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis.
Azuma T; Takei M; Yoshikawa T; Nagasugi Y; Kato M; Otsuka M; Shiraiwa H; Sugano S; Mitamura K; Sawada S; Masuho Y; Seki N
Immunol Lett; 2002 May; 81(3):171-6. PubMed ID: 11947921
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
19. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene expression and autoantibody production in Sjögren's syndrome of MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Autoimmunity; 1996; 23(4):269-77. PubMed ID: 8915033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
